CD163 positive macrophages (M2‐like subtype, anti‐inflammatory) predominated in higher tumor stages and were associated with worse overall survivalCD80 positive macrophages (M1‐like, proinflammatory) were associated with lower tumor stage & lower risk of recurrence. The gene discussed is CD163; the disease is neoplasm.